Toward the goal of developing an optical imaging contrast agent that will enable surgeons to intraoperatively distinguish cancer foci from adjacent normal tissue, we developed a chlorotoxin:Cy5.5 (CTX:Cy5.5) bioconjugate that emits near-IR fluorescent signal. The probe delineates malignant glioma, medulloblastoma, prostate cancer, intestinal cancer, and sarcoma from adjacent non-neoplastic tissue in mouse models. Metastatic cancer foci as small as a few hundred cells were detected in lymph channels. Specific binding to cancer cells is facilitated by matrix metalloproteinase-2 (MMP-2) as evidenced by reduction of CTX:Cy5.5 binding in vitro and in vivo by a pharmacologic blocker of MMP-2 and induction of CTX:Cy5.5 binding in MCF-7 cells following transfection with a plasmid encoding MMP-2. Mouse studies revealed that CTX:Cy5.5 has favorable biodistribution and toxicity profiles. These studies show that CTX:Cy5.5 has the potential to fundamentally improve intraoperative detection and resection of malignancies.
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Publishing Authors By Initials
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Journal Published:
PUBLICATION TYPE: Research Support, Non-U.S. Gov
Journal: Cancer research
VOLUME: 67
Page Numbers: 6882-8
Journal Abbreviation: Cancer Res.
ISSN: 0008-5472
DAY: 15
MONTH: Jul
YEAR: 2007
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 2984705
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Keywords Mesh Terms:
KEYWORDS: Scorpion Venoms
MESH TERMS: chemistry
Chemical & Substance for Abstract: Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Information
Substance Name: Matrix Metalloproteinase 2
Registry Number: EC 3.4.24.24
Grant and Affiliation Information for Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.
AFFILIATION: Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Avenue N., Seattle, WA 98109, USA.
Country: United States
AGENCY: United States NCI
GRANT: P30 CA 15704-31
ACRONYM: CA
MEDLINETA: Cancer Res
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Tumor paint: a chlorotoxin:Cy55 bioconjugate for intraoperative visualization of cancer foci Related Publications